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Purpose: Mutations in the dystrophin (DMD) gene cause Duchenne or Becker muscular dystrophy (DMD/BMD).
DMD contains a retina-specific promoter in intron 29. The short R-dystrophin transcript from this promoter has a retina-
specific exon 1 (R1) joined to exon 30 of the DMD gene. It has been claimed that this is responsible for the ophthalmological
problems observed in DMD/BMD. This research characterizes the structure of the 5′-untranslated region (5′-UTR) of
human R-dystrophin.
Methods: The 5′-UTR of the human R-dystrophin transcript was amplified from human retina and 20 other human tissue
RNAs by reverse transcription polymerase chain reaction (RT–PCR). Amplified products were identified by sequencing.
The translational activities of transcripts bearing differing 5′-UTRs were measured using a dual luciferase assay system.
Results: RT–PCR amplification of the R-dystrophin transcript from the retina using a conventional primer set revealed
one product comprising exon R1 and exons 30 to 32 (R-dys α). In contrast, three amplified products were obtained when
a forward primer at the far 5′-end of exon R1 was employed for RT–PCR. R-dys α, and a shorter form in which 98 bp was
deleted from exon R1 (R-dys β), were the two major products. A minor, short form was also identified, in which 143 bp
was deleted from exon R1 (R-dys γ). The two primary retinal products (R-dys α and β) encoded an identical open reading
frame. The 98 bp deleted in R-dys β was identified as a cryptic intron that was evolutionarily acquired in higher mammals.
The shorter R-dys β was expressed in several tissues with a wide range in expression level, while R-dys α was retina
specific. The 5′-UTRs of R-dys α and β were examined for translational activity using a dual luciferase assay system.
Unexpectedly, the 5′-UTR of R-dys β showed lower translational activity than that of R-dys α. This lower activity was
presumed to be due to the removal of internal ribosome entry sites by activation of cryptic intron splicing.
Conclusions: An evolutionarily-acquired cryptic intron was identified in the 5′-UTR of the human R-dystrophin transcript.
The two abundant R-dystrophin transcripts in the retina showed different translational activities in vitro owing to their
differential splicing of the cryptic intron. This evolutionarily-acquired alternative splicing may act as a molecular switch
that regulates translation of the R-dystrophin transcript.
The dystrophin (DMD) gene is responsible for the most
common inherited muscle diseases, Duchenne and Becker
muscular  dystrophies  (DMD/BMD).  DMD  is  the  largest
known  human  gene,  spanning  more  than  2.5  Mb  on
chromosome  Xp21.2,  and  comprises  79  exons  and  large
introns. At least eight alternative promoters/first exons are
scattered among the introns. Four tissue-specific promoters at
the 5′-end of the gene express full-length dystrophin, while
four internal promoters express smaller isoforms containing
unique first exons that are activated in a tissue-specific manner
[1–3].
An alternative promoter/first exon located within intron
29 is strongly expressed in the retina. The first exon (R1)
splices to exon 30 of the DMD gene to encode R-dystrophin
[3,4]. Exon R1 is 236 bp long and encodes 13 retina-specific
amino acids, leaving 197 bp as the 5′-untranslated region (5′-
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UTR)  [4].  This  protein  has  been  identified  as  human  R-
dystrophin by western blotting of retinal dystrophin proteins
(Dp260) [5]. In addition, a single sequence with a 143-bp
deletion  in  exon  R1  has  been  deposited  in  GenBank
(NM_004011.3).  This  variant  contains  a  95  bp  exon  R1
encoding a unique 16 amino acids of N-terminal end. R-
dystrophin has been shown to be involved in the commitment
of synaptic maturation and attachment of the retina to the
vitreous  [6–8].  Furthermore,  R-dystrophin  has  been
categorized  as  a  cytolinker  in  skeletal  muscle  because  it
organizes costameric microtubules in the skeletal muscle of
transgenic mdx mice expressing R-dystrophin [9].
DMD  and  BMD  have  been  described  to  have
ophthalmological  complications  [8,10,11].  A  reduced
electroretinogram (ERG) b-wave was identified in DMD and
considered a direct consequence of dystrophin deficiency [4,
5,8,10]. A subset of DMD patients with deletions downstream
of exon 30, affecting the splicing and transcription of R-
dystrophin,  exhibit  a  red-green  color  vision  defect,  while
DMD patients who have dystrophin mutations upstream of
exon 30 have seemingly normal color vision [11]. This color
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2590vision defect is likely caused by a loss of R-dystrophin. Thus,
both molecular and clinical findings suggest an important role
for R-dystrophin.
Alternative splicing is a source of genetic variation, and
more than 95% of genes have at least one alternative splicing
site [12]. Alternative splicing within the protein-coding region
attracts much attention, because it is likely to directly impact
protein function. In contrast, alternative splicing in 5′-UTRs
has not been characterized as well. It is known that the 5′-UTR
is a major site of translational regulation through internal
ribosome  entry  sites  (IRES)  [13–15]  or  upstream  AUG
(uAUG) motifs [16]. Abnormalities in the 5′-UTR can be
pathogenic [13,17]. Alternative splicing in the 5′-UTR has
been shown to play a significant role in gene function [18].
However, the 5′-UTR of the human R-dystrophin transcript
has not been well characterized.
Here, we identified an evolutionarily-acquired alternative
splicing pathway in the 5′-UTR of the R-dystrophin transcript.
We showed that transcripts with an alternatively-spliced 5′-
UTR have a lower translational activity than those with a non-
spliced 5′-UTR.
METHODS
Transcript analysis: RT–PCR amplification was conducted to
examine the R-dystrophin transcript. Human total RNAs from
retina and 20 other tissues (adrenal gland, colon, cerebellum,
whole brain, fetal brain, fetal liver, heart, kidney, liver, lung,
placenta,  prostate,  salivary  gland,  skeletal  muscle,  spleen,
testis,  thymus,  thyroid  gland,  trachea,  and  uterus)  were
obtained from a human total RNA Master Panel II (Clontech
Laboratories,  Inc.,  Mountain  View,  CA).  cDNA  was
synthesized as described previously [19] from 2.5 µg of each
total RNA. A retinal promoter-derived transcript spanning
exon R1 to exon 32 was PCR amplified using the following
primers: forward primer, RdysF-N119: 5′-ATG CAG AGA
TCC CTG ATC CTA TAG-3′ [4] and reverse primer on exon
32, 2F: 5′-TTC CAC ACT CTT TGT TTC CAA TG-3′. To
extend the amplified region, another forward primer was used
at the 5′-end of exon R1 (Rdys-F: 5′-GGA GGA ACA TTC
GAC CTG AG-3′). PCR amplification was performed in a
total volume of 20 µl, containing 2 µl of cDNA, 2 µl of 10×
ExTaq buffer (Takara Bio, Inc., Shiga, Japan), 0.5 U of ExTaq
polymerase (Takara Bio, Inc.), 500 nM of each primer and
250 µM dNTPs (Takara Bio, Inc.). Twenty-eight cycles of
amplification were performed on a Mastercycler Gradient
PCR  machine  (Eppendorf,  Hamburg,  Germany)  using  the
following conditions: initial denaturation at 94 °C for 5 min,
subsequent denaturation at 94 °C for 0.5 min, annealing at
59 °C for 0.5 min and extension at 72 °C for 1 min. Amplified
PCR products were electrophoresed on a 2% agarose gel with
a low molecular weight DNA standard (ϕX174-HaeIII digest;
Takara Bio, Inc.), and stained with ethidium bromide.
PCR-amplified bands were excised from the gel with a
sharp  razor,  pooled  and  purified  using  a  QIAGEN  gel
extraction kit (QIAGEN, Inc., Hilden, Germany), according
to  the  manufacturer’s  instructions.  Purified  products  were
subcloned into the pT7 blue T vector (Novagen, Inc., San
Diego, CA), and sequenced using a Taq dye terminator cycle
sequence kit (Life Technologies Corp., Carlsbad, CA) with an
automatic  DNA  sequencer  (3130  Genetic  Analyzer;  Life
Technologies Corp.), as described previously [20]. RT–PCR
products were semi-quantified using a DNA 1000 LabChip
kit on an Agilent 2100 Bioanalyzer (Agilent Technologies,
Santa Clara, CA).
To check the integrity and concentration of the cDNA,
the  glyceraldehyde  3-phosphate  dehydrogenase  (GAPDH)
gene was also RT–PCR amplified, as described previously
[21].
Translational activity assay:
Construction  of  plasmids—To  measure  the
translational activity of the 5′-UTR of dystrophin transcripts,
dual-luciferase reporter assays using the psiCHECK-2 vector
(Promega Corp., Madison, WI), which allows simultaneous
expression  of  Renilla  and  firefly  luciferase  from  a  single
plasmid,  were  conducted  in  HEK293  cells.  The  5′-UTR
sequences  of  R-dys  α  (α5′-UTR)  and  β  (β5′-UTR)  were
inserted into the Renilla luciferase gene. Before inserting the
5′-UTR sequences into the psiCHECK-2 vector, the ATG of
the  Renilla  luciferase  was  mutated  to  TTG,  named
psiCHECK-2-TTG, so that the Renilla luciferase expression
would be driven by the primary ATG initiation codon of the
gene under investigation. The 5′-UTR sequences, up to and
including  the  primary  ATG  initiation  codon,  were  PCR
amplified. The amplified products were cloned and ligated
into the NheI site directly preceding the Renilla luciferase
gene in the plasmid psiCHECK-2-TTG.
The α5′-UTR was PCR amplified using the primers H-
Dp260Ex1-F: 5′-cgc gct agc TAA TGA GAT CAG GAG
GAA CA-3′ and H-Dp260Ex1-α: 5′-cgc gct agc CTC ATT
CAG CTC TGT TGA TA-3′; the β5′-UTR was amplified
using  H-Dp260Ex1-F  and  H-Dp260Ex1-β:  5′-cgc  gct  agc
CTC ATT CAG CTA TTA AGG AA-3′. Upper case letters
corresponded to sequences of the 5′-UTR. Lower case letters
were sequences attached to create an NheI cut site (gct agc).
Luciferase activity assay—HEK293 cells were grown
at 37 °C in a humidified atmosphere containing 5% CO2 in
Dulbecco’s modified Eagle’s medium (Sigma-Aldrich Corp.,
St Louis, MO) supplemented with 10% fetal bovine serum
(Life Technologies Corp.) and 1% PSN antibiotic mixture
(Life  Technologies  Corp.).  HEK293  cells  were  seeded  at
4×105  cells  per  well  in  12-well  dishes.  After  overnight
incubation, the cells grew to approximately 80% confluency
and  800  ng  of  each  of  the  three  vector  constructs  (the
unmodified  plasmid  psiCHECK-2-TTG  and  the  plasmids
psiCHECK-2-α and -β) were transfected into the cells using
Lipofectamine™ 2000 (Life Technologies Corp.). Twenty-
four h after transfection, cells were washed with phosphate-
buffered  saline  and  resuspended  in  Passive  Lysis  Buffer
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were  measured  using  a  dual-luciferase  reporter  assay  kit
(Promega Corp.) with a plate reader (Fluoroskan Ascent FL;
Thermo Fisher Scientific., Waltham, MA), according to the
manufacturer’s instructions. All experiments were performed
in triplicate. To account for nonspecific effects on reporter
plasmids,  experimental  results  were  expressed  as  a
normalized ratio. The ratio of Renilla and firefly luciferase
activity  was  normalized  against  the  unmodified  plasmid
psiCHECK-2-TTG.  The  relative  ratio  of  Renilla/firefly
luciferase activity determined from cells transfected with the
plasmid psiCHECK-2-α was set at 1 and was compared with
that determined from the plasmid psiCHECK-2-β.
Analysis: The probability scores for the splice acceptor and
donor  sites  were  calculated  as  described  previously  [22].
Statistical significance was examined using Student’s t test
using  GraphPad  Prism  software,  version  5.02  (GraphPad
Software Inc., San Diego, CA). A significant difference was
Figure 1. Reverse transcription polymerase chain reaction (RT–PCR) amplification of the R-dystrophin transcript. A: Schematic description
of the region encompassing exons R1 to 32 of the dystrophin (DMD) gene. RT–PCR primers (RdysF-N119, Rdys-F and 2F) are shown as
horizontal arrows. Boxes and bars indicate exons and introns, respectively. Exon/intron structures are described according to previous studies
and the present study above and below the line, respectively. In this study, exon R1 is divided into three segments: the boxes labeled R1A
(horizontal-lined), IR1A (black) and R1B (vertical bold-lined) represent exon R1A (93 bp), intron R1A (98 bp) and exon R1B (45 bp),
respectively. Intron R1 was also incorporated into the mRNA (oblique-lined box). Numbers within the boxes indicate the exon number. The
actual lengths of exon R1 and intron R1 are 236 bp and 105 bp, respectively. B: RT–PCR-amplified products of the fragment encompassing
exons R1 to 32. Amplification from the retina using the conventional primer RdysF-N119 revealed one clear band of 529 bp (R-dys α; right).
In contrast, RT–PCR amplification using the outer forward primer Rdys-F revealed three bands: two major products of 636 bp and 538 bp
(R-dys α and β, respectively) and one weak product of 493 bp (R-dys γ; left). In addition, sequencing of subclones revealed an additional,
larger product (R-dys δ). The exon structure of each product is described in the middle of each panel. The four R-dystrophin transcripts are
shown by four bars. A fragment of GAPDH (302 bp) was amplified as a control (bottom). MK refers to the size marker (φX174 HaeIII digest).
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structure of the 5′-UTR was analyzed using Mfold, version
3.2. Internal ribosome entry sites (IRESs) were analyzed using
IRESite.
RESULTS
Retinal dystrophin transcript: To characterize the 5′-UTR of
the R-dystrophin transcript, a region from exon R1 to exon 32
was RT–PCR amplified from human retina RNA using a
conventional forward primer on exon R1 (RdysF-N119) and
a reverse primer on exon 32 (2F). One clear PCR-amplified
product was obtained that comprised exons R1, 30, 31, and 32
(R-dys α) (Figure 1), as described previously [4]. This agreed
with the current understanding of retinal dystrophin [11].
To examine the full length of exon R1, the same region
was amplified using an outer forward primer (Rdys-F), 107
bp upstream of RdysF-N119 and located at the far 5′-end of
exon R1. Three amplified products were visualized on agarose
gels, with two major products and one minor product (Figure
1). Among the two major products, the longer product was
identical to R-dys α. The shorter major product had the same
exon content as R-dys α but had a 98-bp deletion within exon
R1 located 45 bp upstream of the 3′-end of exon R1 (R-dys
β; Figure 1). R-dys β was a novel variant of the R-dystrophin
transcript. Because the ATG start codon is present within the
common 45-bp region, the translational reading frame of both
R-dys α and β was identical. R-dys β was expressed at a similar
level to R-dys α in the retina, and it was speculated that the R-
dys β may be physiologically important. The minor PCR band
was identified to have a 143-bp deletion in exon R1 that
shortened it to 93 bp (R-dys γ; GenBank NM_004011.3). In
addition to the three visible products, a clone of 741 bp was
identified by sequencing of subclones. This clone retained a
105-bp intron R1 between exons R1 and 30 (R-dys δ; Figure
1). This is suggested to be an immature mRNA transcribed
from the R-dystrophin promoter.
Alternative  splicing  of  the  5′-UTR  of  R-dystrophin:  The
difference between the two major retinal transcripts (R-dys
α and β) was the absence or presence of the 98-bp sequence
from their 5′-UTRs. Examination of this sequence revealed
GT and AG dinucleotides at its 5′- and 3′-end, respectively
(Figure 2). The probability scores for these dinucleotides to
act as splice donor (GT) or acceptor (AG) sites were calculated
as 0.76 and 0.93, respectively. These values were within the
ranges of scores for the rest of DMD [23]. It was concluded
that the 98-bp region is a novel cryptic intron embedded within
exon R1. As a result, the 236-bp exon R1 can be divided into
three segments: the 93-bp exon R1A, the 98-bp intron R1A
and  the  45-bp  exon  R1B  (Figure  1  and  Figure  2).  The
difference  between  R-dys  α  and  β  was  thus  caused  by
alternative splicing of intron R1A.
Alternative splicing of intron R1A has not been described
in previous reports [4,24]. It was found that the cryptic intron
R1A was evolutionarily acquired in humans but is not present
in rodents, in which intensive studies on R-dystrophin have
been conducted [25]. The mouse and rat genomic sequences
corresponding to the human donor and acceptor sites of intron
R1A have GT/AA and AT/AA, respectively, compared with
GT/AG  in  humans  (underlining  indicates  a  mismatched
nucleotide;  Figure  2).  Evolutionarily  higher  animals,
Figure 2. Genomic sequence of exon R1. A: Features of exon R1 (236 bp; GenBank NW_001842360.1). The 98-bp sequence, deleted in some
transcripts and presumed to be a cryptic intron, is marked by a box. This sequence starts with GT and ends with AG (shaded). Bars below the
sequence indicate internal ribosome entry sites. Dots over the ATG codons indicate a translation start site. B: Consensus dinucleotide sequences
for the cryptic intron. The AG and GT splice consensus dinucleotides are present in humans and other mammals, including chimpanzee,
orangutan and rhesus macaque. The mouse and rat genomic sequences contain GT/AA and AT/AA, respectively.
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have the same sequence as humans in this region (Figure 2).
Tissue distribution of R-dystrophin variants: To examine the
tissue  expression  patterns  of  the  four  variants  of  the  R-
dystrophin transcript, RT–PCR amplification using an outer
forward primer was conducted in 21 human tissue RNAs.
Semi-quantitative analysis was conducted in the retina and the
skeletal muscle where retina- and muscle-specific promoters
were active, respectively (Figure 3). In the retina, four variants
could be detected, but R-dys α and β were the two main
products.  Expression  levels  of  R-dys  α  and  β  were  not
significantly different. In the skeletal muscle, R-dys α, β, and
γ were not detected but R-dys δ was marginally amplified.
Unexpectedly, R-dys β, the shorter retinal product, was clearly
amplified not only in the retina but also in the adrenal gland
(Figure 3). Furthermore, R-dys β was detected weakly in the
fetal liver, the lung, the placenta and the spleen. Expression
of R-dys α was observed strongly in the retina and weakly in
the cerebellum but not in any other tissues. It is interesting that
R-dys α was detected weakly in the cerebellum (Figure 3)
because R-dys α has been proposed to have a neuron-specific
function [6–8].
Translational differences mediated by the 5′-UTRs of R-dys
α and β: Although R-dys α and R-dys β encode an identical
protein, they may be differentially translated in human tissues,
because of their differing 5′-UTRs (α5′-UTR and β5′-UTR,
respectively).  Using  a  dual  luciferase  assay  system,  the
translational activity of the β5′-UTR was significantly lower
than  that  of  the  α5′-UTR  (0.71±0.01  versus  1.00±0.01)
(Figure 4). It was concluded that R-dys β is translated at a
lower  level  than  R-dys  α,  even  though  it  is  more  widely
expressed. Thus, R-dys α was considered more important in
regards to protein production.
Figure 3. R-dystrophin variants in human tissues. A: Semi-quantitative analysis of R-dystrophin variants in the retina and the skeletal muscle.
The ratio of each variant/GAPDH in the retina (R) and the skeletal muscle (M) are shown. A fragment comprising exons R1 to 32 was RT–
PCR amplified from the retina and the skeletal muscle and semi-quantitated. The value was obtained by three quantifications and shown as
mean±SD. In the retina (R), strong expression of R-dys α (α) and β (β) was observed. However, no significant difference between R-dys α
and β was observed (0.70±0.05 and 1.03±0.16, respectively). In the skeletal muscle (M), R-dys α, β and γ (γ) were not detected but R-dys δ
(δ) was observed at the quite low level. B: RT–PCR amplified products are shown. A fragment comprising exons R1 to 32 was RT–PCR
amplified from 21 human tissues. Four products were obtained from the retina (R-dys α, β, γ, and δ) but R-dys α and β were the main products.
R-dys α was also identified weakly in the cerebellum. R-dys β was present in several tissues including the adrenal gland. MK refers to the
size marker (DNA 1000 Markers).
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difference  between  R-dys  α  and  β,  their  5′-UTRs  were
examined for upstream open reading frames (uORFs) [26,
27] or secondary structure [28], but no clear explanation was
Figure 4. Translational activity of the 5′-UTR. A: Structure of the
expression vector and inserted sequence. The psiCHECK-2 PCR
vector is described (bottom). This vector contains the Renilla (R) and
firefly (F) luciferases as the upstream and downstream cistrons,
respectively. Both the α5′-UTR and the β5′-UTR were amplified
(upper and middle, respectively) and inserted into the cloning site.
Before inserting the 5′-UTR sequences into the psiCHECK-2 vector,
the ATG of the Renilla luciferase was mutated to TTG, so that the
Renilla luciferase expression would be driven by the primary ATG
initiation codon (reverse triangle) of the gene under investigation.
B:  Luciferase  activity.  Three  vector  constructs  (the  unmodified
plasmid psiCHECK-2-TTG and plasmids psiCHECK-2-α and -β)
were transfected into HEK293 cells, and the firefly and Renilla
luciferase  activities  were  measured  24  h  after  transfection.  All
experiments were performed in triplicate. The ratio of Renilla and
firefly luciferase activity was normalized against the unmodified
plasmid  psiCHECK-2-TTG.  The  relative  ratio  of  Renilla/firefly
luciferase activity determined from cells transfected with the plasmid
psiCHECK-2-α was set at 1. The relative ratio of Renilla/firefly
luciferase activity was significantly lower for the β5′-UTR than for
the α5′-UTR (0.71±0.01 and 1.00±0.01, respectively).
obtained.  When  IRESs,  which  are  considered  to  regulate
translation [29,30], were analyzed, four IRES motifs were
identified  within  the  98-bp  intron  R1A,  and  four  were
identified within the 93-bp exon R1A (Figure 2). Because
intron R1A was rich in IRES motifs, R-dys β, which lacks
intron R1A, was considered weak for translational activity.
DISCUSSION
In this study of the 5′-UTR of the R-dystrophin transcript, four
different transcripts were identified in human retina (Figure
1). Two (R-dys α and γ) were previously known (GenBank,
NM_004012.3  and  NM_004011.3,  respectively),  and  two
new  transcripts  (R-dys  β  and  δ)  were  cloned.  Alternative
splicing was shown to provide diversity in the transcripts
produced  from  the  retinal  promoter,  and  a  new,
evolutionarily-acquired intron was identified within exon R1
(Figure 2). Among the four transcripts, two (R-dys α and β)
were  the  primary  products  in  the  retina  (Figure  1);  these
encode an identical open reading frame but have different 5′-
UTRs, depending on the pattern of intron R1A splicing. It is
proposed that splicing of the cryptic intron R1A in the 5′-UTR
is a key regulator of the physiologic roles of these variants.
Considering that R-dys β was expressed in several human
tissues (Figure 3), the production of R-dys β was considered
the  default  pathway  for  the  R-dystrophin  transcript.  It  is
supposed that an unidentified retina-specific factor shifts this
default pathway to include the cryptic intron R1A in the retina,
thereby producing R-dys α. R-dys α has a higher translational
activity  than  R-dys  β,  at  least  in  vitro  (Figure  4),  which
produces R-dystrophin in the retina.
Intron  R1A  was  found  to  have  been  acquired  during
evolution between rodents and primates (Figure 2), suggesting
a higher physiologic role for the alternative splicing of cryptic
intron R1A. Important roles for alternative splicing in the 5′-
UTR have been demonstrated in the regulation of translation
in certain human genes [12,13,18,27]. The β5′-UTR, without
intron R1A, showed lower translational activity than the α5′-
UTR  in  a  dual  luciferase  assay  (Figure  4).  This  result  is
contrary to the understanding that a long 5′-UTR suppresses
translation  by  increasing  the  energy  that  a  navigating
ribosome needs to reach the AUG through a highly structured
5′-UTR, stable secondary structures or multiple uORFs [17].
Intron  R1A  retained  in  the  α5′-UTR  seemed  to  increase
translation of R-dys α by virtue of multiple IRESs (Figure 4).
It is known that mRNAs encoding proteins involved in cell
growth, proliferation and apoptosis have structured 5′-UTRs
that harbor IRESs [13]. Therefore, R-dys α retaining many
IRESs is supposed to have an important physiologic role.
Although an ERG abnormality and a red-green color vision
defect have been identified in DMD [11,31], the two variants
identified  in  the  retina  are  considered  to  explain  these
abnormalities. Further studies analyzing mutations in the 5′-
UTR region are required to clarify this.
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cerebellum  (Figure  3).  This  may  correlate  with  synaptic
junction  formation  in  these  tissues  [7,32–35].  No  clear
abnormalities in the cerebellum of DMD patients have been
reported; however, it is possible that a cerebellar phenotype
may be revealed as a more precise examination of cerebellar
function  becomes  possible,  or  when  DMD  patients  can
survive for longer than at present. One third of DMD patients
show mental retardation [36], but direct genotype-phenotype
correlations have not been established for mental retardation
in DMD [37]. It would be interesting to analyze alternative
splicing of R-dystrophin in relation to mental retardation in
DMD.
R-dys  β  was  produced  by  activated  splicing  of  both
introns R1A and R1 from the transcript. This suggests that the
same splicing factors facilitate the splicing of both introns.
Conversely, in the retina, an unidentified splicing factor may
inhibit splicing of intron R1A. Clarification of these factors
may facilitate understanding of the physiologic roles of the
two variants. The pattern of intron R1A alternative splicing
was shown to be key in determining translational activity
(Figure 4). IRESs have been reported to provide molecular
switches, allowing maintenance of the expression of proteins
essential for cell survival or death [13]. Thus, the alternative
splicing  of  intron  R1A  may  act  as  a  molecular  switch
regulating the expression of R-dystrophin in the retina. The
evolution  of  alternative  splicing  in  the  5′-UTR  has  been
proposed to contribute to the regulation of translation [18].
Our results add another example of an evolutionarily-acquired
alternative  splicing  pathway  that  regulates  translational
activity.
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